Black Diamond Therapeutics Inc (NASDAQ: BDTX) on Monday, plunged -3.02% from the previous trading day, before settling in for the closing price of $3.31. Within the past 52 weeks, BDTX’s price has moved between $1.62 and $7.66.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 23.44%. With a float of $43.06 million, this company’s outstanding shares have now reached $51.65 million.
The firm has a total of 54 workers. Let’s measure their productivity. In terms of profitability, gross margin is 77.91%, operating margin of -1782.65%, and the pretax margin is -1645.87%.
Black Diamond Therapeutics Inc (BDTX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Black Diamond Therapeutics Inc is 23.80%, while institutional ownership is 72.17%. The most recent insider transaction that took place on Aug 28 ’24, was worth 1,400,556. In this transaction 10% Owner of this company sold 221,600 shares at a rate of $6.32, taking the stock ownership to the 3,726,341 shares. Before that another transaction happened on Jul 31 ’24, when Company’s Former Employer proposed sale 50,000 for $6.20, making the entire transaction worth $310,000.
Black Diamond Therapeutics Inc (BDTX) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.45 earnings per share (EPS) for the period topping the consensus outlook (set at -0.49) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.44% per share during the next fiscal year.
Black Diamond Therapeutics Inc (NASDAQ: BDTX) Trading Performance Indicators
Black Diamond Therapeutics Inc (BDTX) is currently performing well based on its current performance indicators. A quick ratio of 6.87 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.35 in one year’s time.
Technical Analysis of Black Diamond Therapeutics Inc (BDTX)
Analysing the last 5-days average volume posted by the [Black Diamond Therapeutics Inc, BDTX], we can find that recorded value of 0.67 million was lower than the volume posted last year of 0.83 million. As of the previous 9 days, the stock’s Stochastic %D was 20.30%. Additionally, its Average True Range was 0.32.
During the past 100 days, Black Diamond Therapeutics Inc’s (BDTX) raw stochastic average was set at 2.21%, which indicates a significant decrease from 7.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.69% in the past 14 days, which was lower than the 85.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.87, while its 200-day Moving Average is $4.89. Now, the first resistance to watch is $3.31. This is followed by the second major resistance level at $3.41. The third major resistance level sits at $3.48. If the price goes on to break the first support level at $3.14, it is likely to go to the next support level at $3.07. Should the price break the second support level, the third support level stands at $2.97.
Black Diamond Therapeutics Inc (NASDAQ: BDTX) Key Stats
Market capitalization of the company is 181.37 million based on 56,253K outstanding shares. Right now, sales total 0 K and income totals -82,440 K. The company made 0 K in profit during its latest quarter, and -19,910 K in sales during its previous quarter.
